Pr Christophe Massard, Oncologue médical, expert vessie, expert prostate

Spécialité

Oncologue médical, expert vessie, expert prostate

Titre

Chef du Département des Essais Précoces (DITEP)

Hôpital

Gustave Roussy (Villejuif)

Derniers articles

Relevance, Risks, and Benefits of Early-Phases Clinical Trials Participations for Patients With Hematological Malignancies From 2008 to 2023. (1 janv. 2025)
Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase Trials. (3 déc. 2024)
Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancer. (30 oct. 2024)
The genomic and transcriptomic landscape of metastastic urothelial cancer. (4 oct. 2024)
Assessing actionability and incidental findings of germline variants in two precision oncology trials. (1 oct. 2024)